Efavirenz Reclassified as FDA Pregnancy Category D
HIV/AIDS Clinical Care News in Context
Subscription Required
Following a fourth retrospective report of neural tube defect in a fetus exposed to efavirenz during the first trimester, the teratogenic status of this agent has been upgraded.
By Lynne M. Mofenson, MD
February 1, 2005
Avoid PPIs with Atazanavir
HIV/AIDS Clinical Care News in Context
Subscription Required
FDA Approves OraQuick for Use in Saliva
HIV/AIDS Clinical Care News in Context
Subscription Required
On March 25, the FDA approved the first rapid test for HIV in oral fluids.
By Bernard M. Branson, MD
May 1, 2004
New Nevirapine Label Underscores the Risk for Hepatotoxicity in Key Populations
HIV/AIDS Clinical Care News in Context
Subscription Required
By Matthew O'Rourke
March 1, 2004
Controversy over Ritonavir Price Increase
HIV/AIDS Clinical Care News in Context
Subscription Required
The two professional HIV medical associations take issue with a sharp increase in the cost of ritonavir, and the manufacturer responds.
By ACC Editors
February 1, 2004
T-1249 Development Hits a Snag
HIV/AIDS Clinical Care News in Context
Subscription Required
New Clinical trials of this promising second-generation fusion inhibitor are on hold while the manufacturer addresses problems with the formulation.
By ACC Editors
February 1, 2004
In Memoriam
HIV/AIDS Clinical Care News in Context
Subscription Required
All of us at AIDS Clinical Care join the world in mourning the untimely deaths of Jonathan Mann and Mary Lou Clements-Mann. We can think . . .
Preliminary Report on 1592
HIV/AIDS Clinical Care News in Context
Subscription Required
According to investigators, preliminary data indicate that the investigational nucleoside analogue 1592 (Glaxo-Wellcome) is a powerful antiretroviral, comparing favorably with other potent agents such as . . .
AIDS Deaths Decline
HIV/AIDS Clinical Care News in Context
Subscription Required
The Centers for Disease Control and Prevention recently issued a report showing, for the first time, a marked decline in total U.S. AIDS deaths. Pub- . . .
By Danielle Sullivan and Paul E. Sax, MD
April 1, 1997
Home HIV Test Goes to Market
HIV/AIDS Clinical Care News in Context
Subscription Required
After almost a decade spent weighing the benefits and risks of home HIV testing, the FDA has finally given the go-ahead to this novel diagnostic . . .
By Abigail Zuger, MD
July 1, 1996
